Correction: Soluble urokinase plasminogen activator receptor and cardiotoxicity in doxorubicin‑treated breast cancer patients: a prospective exploratory study.

Autor: Chu J; Department of Internal Medicine, Rush University Medical Center, Chicago, IL, USA., Tung L; Department of Internal Medicine, Rush University Medical Center, Chicago, IL, USA., Atallah I; Department of Internal Medicine, Division of Cardiology, Saint Louis University Hospital, St. Louis, MO, USA., Wei C; Department of Internal Medicine, Rush University Medical Center, Chicago, IL, USA., Cobleigh M; Department of Internal Medicine, Section of Hematology/Oncology, Rush University Medical Center, Chicago, IL, USA., Rao R; Department of Internal Medicine, Section of Hematology/Oncology, Rush University Medical Center, Chicago, IL, USA., Feinstein SB; Department of Internal Medicine, Division of Cardiology, Rush University Medical Center, 1717 West Congress Parkway | Kellogg Bldg, Suite 328, Chicago, IL, 60612, USA., Usha L; Department of Internal Medicine, Section of Hematology/Oncology, Rush University Medical Center, Chicago, IL, USA., Banach K; Department of Internal Medicine, Division of Cardiology, Rush University Medical Center, 1717 West Congress Parkway | Kellogg Bldg, Suite 328, Chicago, IL, 60612, USA., Reiser J; Department of Internal Medicine, Rush University Medical Center, Chicago, IL, USA., Okwuosa TM; Department of Internal Medicine, Division of Cardiology, Rush University Medical Center, 1717 West Congress Parkway | Kellogg Bldg, Suite 328, Chicago, IL, 60612, USA. tokwuosa@rush.edu.
Jazyk: angličtina
Zdroj: Cardio-oncology (London, England) [Cardiooncology] 2024 Feb 06; Vol. 10 (1), pp. 5. Date of Electronic Publication: 2024 Feb 06.
DOI: 10.1186/s40959-024-00205-5
Databáze: MEDLINE
Externí odkaz: